Noordam Raymond, Aarts Nikkie, Verhamme Katia M, Sturkenboom Miriam C M, Stricker Bruno H, Visser Loes E
Department of Epidemiology, Erasmus MC-University Medical Center Rotterdam, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands.
Eur J Clin Pharmacol. 2015 Mar;71(3):369-75. doi: 10.1007/s00228-014-1803-x. Epub 2015 Jan 6.
Antidepressant drug use increases worldwide. It is pivotal to closely monitor the use of antidepressants and to determine in what subpopulations the rise is most substantial. In a Dutch primary care database, we aimed to investigate the (sex- and age-specific) prevalence and incidence of antidepressant prescription and to monitor the indication of incident prescriptions over a 17-year period (1996-2012).
This study, embedded in the Integrated Primary Care Information database, included all patients aged 10 years or older. Per calendar year, prevalence and incidence of antidepressant drug prescription were calculated by drug class (tricyclic antidepressants, selective serotonin reuptake inhibitors (SSRIs), and others), sex, and age. The indication of incident prescriptions (e.g., depression, anxiety, sleep disorders, and neuropathic pain) was determined based on the International Classification of Primary Care codes.
In total, 1.49 million patients were included. For all antidepressants together, the prevalence increased over time. However, incident prescription of specific SSRIs decreased from 2000 onward. During the study period, incidence and prevalence were higher in older and female patients. The increase in prevalence and the decrease in incidence were more pronounced in females than that in males. Furthermore, antidepressants were increasingly prescribed for indications such as neuropathic pain and sleep disorders.
In Dutch primary care, prevalent prescription of antidepressants continued to increase, but incident prescription of particular SSRIs decreased from 2000 onward. In later years, antidepressants were less frequently prescribed for depression-related indications in incident users.
全球范围内抗抑郁药物的使用呈上升趋势。密切监测抗抑郁药物的使用情况并确定哪些亚人群的增长最为显著至关重要。在一个荷兰初级保健数据库中,我们旨在调查抗抑郁药物处方的(性别和年龄特异性)患病率和发病率,并在17年期间(1996 - 2012年)监测新发处方的适应症。
本研究纳入综合初级保健信息数据库中所有10岁及以上的患者。按日历年,通过药物类别(三环类抗抑郁药、选择性5-羟色胺再摄取抑制剂(SSRI)及其他)、性别和年龄计算抗抑郁药物处方的患病率和发病率。根据初级保健国际分类编码确定新发处方的适应症(如抑郁症、焦虑症、睡眠障碍和神经性疼痛)。
共纳入149万患者。所有抗抑郁药物的总体患病率随时间增加。然而,特定SSRI的新发处方自2000年起下降。在研究期间,老年患者和女性患者的发病率和患病率更高。患病率的增加和发病率的下降在女性中比男性更明显。此外,抗抑郁药物越来越多地用于治疗神经性疼痛和睡眠障碍等适应症。
在荷兰初级保健中,抗抑郁药物的普遍处方持续增加,但特定SSRI的新发处方自2000年起下降。在后期,新发使用者中抗抑郁药物用于抑郁症相关适应症的频率较低。